Developing patient-centred, feasible alternative care for adult emergency department users with epilepsy: protocol for the mixed-methods observational 'Collaborate' project.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 11 2019
Historique:
entrez: 4 11 2019
pubmed: 5 11 2019
medline: 6 11 2020
Statut: epublish

Résumé

Emergency department (ED) visits for epilepsy are common, costly, often clinically unnecessary and typically lead to little benefit for epilepsy management. An 'Alternative Care Pathway' (ACP) for epilepsy, which diverts people with epilepsy (PWE) away from ED when '999' is called and leads to care elsewhere, might generate savings and facilitate improved ambulatory care. It is unknown though what features it should incorporate to make it acceptable to persons from this particularly vulnerable target population. It also needs to be National Health Service (NHS) feasible. This project seeks to identify the optimal ACP configuration. Mixed-methods project comprising three-linked stages. In Stage 1, NHS bodies will be surveyed on ACPs they are considering and semi-structured interviews with PWE and their carers will explore attributes of care important to them and their concerns and expectations regarding ACPs. In Stage 2, Discrete Choice Experiments (DCE) will be completed with PWE and carers to identify the relative importance placed on different care attributes under common seizure scenarios and the trade-offs people are willing to make. The uptake of different ACP configurations will be estimated. In Stage 3, two Knowledge Exchange workshops using a nominal group technique will be run. NHS managers, health professionals, commissioners and patient and carer representatives will discuss DCE results and form a consensus on which ACP configuration best meets users' needs and is NHS feasible. Ethical approval: NRES Committee (19/WM/0012) and King's College London ethics Committee (LRS-18/19-10353). Primary output will be identification of optimal ACP configuration which should be prioritised for implementation and evaluation. A pro-active dissemination strategy will make those considering developing or supporting an epilepsy ACP aware of the project and opportunities to take part in it. It will also ensure they are informed of its findings. Researchregistry4723.

Identifiants

pubmed: 31678950
pii: bmjopen-2019-031696
doi: 10.1136/bmjopen-2019-031696
pmc: PMC6830638
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e031696

Subventions

Organisme : Department of Health
ID : 17/05/62
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2015 Jul 24;5(7):e009040
pubmed: 26209121
Pharmacoeconomics. 2014 Sep;32(9):883-902
pubmed: 25005924
Epilepsia. 2013 Apr;54(4):708-17
pubmed: 23346922
BMJ. 2014 Jun 23;348:g4072
pubmed: 24957899
Epilepsy Behav. 2010 Sep;19(1):36-42
pubmed: 20638344
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
BMJ Open. 2016 Jan 20;6(1):e010100
pubmed: 26792220
Seizure. 2017 Aug;50:33-37
pubmed: 28601689
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
BMJ Open. 2016 Nov 9;6(11):e014022
pubmed: 28186950
J Neurol. 2013 Apr;260(4):1022-30
pubmed: 23161462
Pharmacoeconomics. 2008;26(8):661-77
pubmed: 18620460
Epilepsia. 2012 Oct;53(10):1820-8
pubmed: 22779409
Epilepsy Res. 2008 May;79(2-3):120-9
pubmed: 18339521
Br J Gen Pract. 1999 Apr;49(441):285-9
pubmed: 10736906
Br J Health Psychol. 2011 Nov;16(4):862-79
pubmed: 21988069
Seizure. 2004 Sep;13(6):425-33
pubmed: 15276147
Health Econ. 2012 Feb;21(2):145-72
pubmed: 22223558
Qual Saf Health Care. 2004 Dec;13(6):435-43
pubmed: 15576705
BMJ Open. 2015 Mar 31;5(3):e007325
pubmed: 25829372
Epilepsia. 1998 Jul;39(7):776-86
pubmed: 9670907
J Accid Emerg Med. 1998 Jul;15(4):237-43
pubmed: 9681306
Emerg Med J. 2002 Sep;19(5):449-52
pubmed: 12205005
Epilepsia. 2000 Aug;41(8):1014-9
pubmed: 10961629
BMJ Open. 2016 Feb 23;6(2):e010573
pubmed: 26908532
BMJ Open. 2018 Oct 21;8(10):e023352
pubmed: 30344177
Epilepsy Res. 1995 May;21(1):51-8
pubmed: 7641676
Emerg Med J. 2013 Mar;30(3):236-40
pubmed: 22433590
Health Econ. 2017 Jun;26(6):810-817
pubmed: 27122445
Med Decis Making. 2017 Apr;37(3):298-313
pubmed: 28061040
Br J Gen Pract. 2007 Jun;57(539):441-8
pubmed: 17550668
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Seizure. 2000 Apr;9(3):216-20
pubmed: 10775519
Psychosom Med. 2005 Nov-Dec;67(6):997-1005
pubmed: 16314606
Br J Clin Pharmacol. 2015 Nov;80(5):1149-59
pubmed: 26138622
Br J Gen Pract. 2011 May;61(586):e271-8
pubmed: 21619751
Health Econ. 2012 Jun;21(6):730-41
pubmed: 21557381
Epilepsy Behav. 2017 Mar;68:192-195
pubmed: 28219054
BMJ Open. 2013 Jan 02;3(1):null
pubmed: 23288268
Epilepsy Behav. 2012 Dec;25(4):529-33
pubmed: 23159376
J Health Econ. 2008 Jul;27(4):1078-1094
pubmed: 18179837
BMJ Open. 2017 Jan 9;7(1):e014024
pubmed: 28069626
Seizure. 2013 Nov;22(9):698-702
pubmed: 23810711
Epilepsy Behav. 2019 Jan;90:228-232
pubmed: 30573339
BMJ Open. 2017 Aug 3;7(8):e016832
pubmed: 28775192
BMJ. 2015 Jun 18;350:h3284
pubmed: 26088572
BMC Neurol. 2014 Apr 03;14:69
pubmed: 24694207
BMJ. 1995 Jul 8;311(6997):109-12
pubmed: 7613363
Epilepsy Behav. 2013 Sep;28(3):379-85
pubmed: 23856071

Auteurs

Adam J Noble (AJ)

Department of Health Services Research, University of Liverpool, Liverpool, UK adam.noble@liverpool.ac.uk.

Amy Mathieson (A)

Department of Health Services Research, University of Liverpool, Liverpool, UK.

Leone Ridsdale (L)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

E A Holmes (EA)

Centre for Health Economics & Medicines Evaluation, Bangor University, Bangor, UK.

Myfanwy Morgan (M)

Institute of Pharmaceutical Science, King's College London, London, UK.

Alison McKinlay (A)

Basic & Clinical Neuroscience, King's College London, London, UK.

Jon Mark Dickson (JM)

Academic Unit of Primary Medical Care, The University of Sheffield, Sheffield, UK.

Mike Jackson (M)

North West Ambulance Service NHS Trust, Bolton, UK.

Dyfrig A Hughes (DA)

Centre for Health Economics & Medicines Evaluation, Bangor University, Bangor, UK.
Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.

Steve Goodacre (S)

Medical Care Research Unit, University of Sheffield, Sheffield, UK.

Anthony G Marson (AG)

Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH